NSGC 2026 has ended. This guide stays up as the record of who was there. Next: NSGC 2027, Nov 7–11, 2027 in Tampa

Ascendis Pharma at NSGC 2026

Nov 10–14, 2026 Baltimore, MD ~2.5k attendees Website

Ascendis Pharma takes part in 1 session at NSGC 2026 in Baltimore, and exhibits at Booth 1055. Ascendis Pharma's breakfast symposium introduces Yuviwel (navepegritide), covering how the medicine works, what its clinical trials showed and how it is dosed. The company develops long-acting treatments for rare endocrine and skeletal conditions, achondroplasia among them.

OrganizationNSGC 2026 Attendance
Ascendis Pharma
Copenhagen, Denmark
Pharma and biotech companies
Biopharmaceutical company developing long-acting treatments for rare endocrine and skeletal conditions, including achondroplasia.
Booth
Exhibiting at Booth 1055
Wed, Nov 1110am–12:15pm · 3–6:30pmThu, Nov 1210:15am–12:15pm · 3–5:30pmFri, Nov 1310:15am–12:15pm
Symposium
Wed Nov 11
7:45–8:30am
Discover Yuviwel® (navepegritide)
Introduces Ascendis' Yuviwel (navepegritide), covering how it works, its clinical trial results and how it is dosed.
Rare disease

Explore the full NSGC 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Baltimore. Leave your work email and we’ll be in touch.

Privacy

Download the full NSGC 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Ascendis Pharma

Tell us what you sell and we’ll find the people at Ascendis Pharma most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the National Society of Genetic Counselors (NSGC). Organization details are derived from NSGC’s published exhibitor list and program, and each organization’s own website. Submit a correction